DDC
Daniel Devine & Co Portfolio holdings
AUM
$125M
This Quarter Return
+0.38%
1 Year Return
+14.12%
3 Year Return
+34.19%
5 Year Return
–
10 Year Return
–
AUM
$153M
AUM Growth
+$153M
(+1.3%)
Cap. Flow
+$1.75M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
56.18%
Holding
69
New
1
Increased
16
Reduced
16
Closed
11
Top Buys
| 1 |
Robert Half
RHI
|
$1.88M |
| 2 |
Novartis
NVS
|
$1.18M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$1.17M |
| 4 |
AstraZeneca
AZN
|
$994K |
| 5 |
AbbVie
ABBV
|
$811K |
Top Sells
| 1 |
Verizon
VZ
|
$1.59M |
| 2 |
Consolidated Edison
ED
|
$1.34M |
| 3 |
W.W. Grainger
GWW
|
$1.16M |
| 4 |
Southern Company
SO
|
$880K |
| 5 |
Philip Morris
PM
|
$782K |
Sector Composition
| 1 | Healthcare | 11.87% |
| 2 | Industrials | 9.69% |
| 3 | Financials | 8.43% |
| 4 | Technology | 7.09% |
| 5 | Materials | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $29.1M | 19% |
141,810
+5,715
| +4% | +$1.17M |
|
2
Invesco QQQ Trust
QQQ
$364B
| $13.2M | 8.59% |
120,755
-500
| -0.4% | -$54.6K |
|
3
SPDR S&P MidCap 400 ETF Trust
MDY
$23.7B
| $12.3M | 8.02% |
46,815
| – | – |
|
4
Apple
AAPL
$3.45T
| $7.5M | 4.89% |
68,797
+140
| +0.2% | +$15.3K |
|
5
Johnson & Johnson
JNJ
$427B
| $5.19M | 3.38% |
47,932
| – | – |
|
6
VanEck Oil Services ETF
OIH
$886M
| $4.54M | 2.96% |
170,700
-2,060
| -1% | -$54.8K |
|
7
GE Aerospace
GE
$292B
| $4.17M | 2.71% |
131,001
-3,100
| -2% | -$98.6K |
|
8
Industrial Select Sector SPDR Fund
XLI
$23.3B
| $4.16M | 2.71% |
74,965
| – | – |
|
9
iShares Biotechnology ETF
IBB
$5.6B
| $3.09M | 2.02% |
11,855
+90
| +0.8% | +$23.5K |
|
10
Chevron
CVX
$324B
| $2.93M | 1.91% |
30,657
+4,480
| +17% | +$427K |
|
11
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.91M | 1.9% |
20,500
+5,000
| +32% | +$710K |
|
12
iShares MSCI Emerging Markets ETF
EEM
$19B
| $2.77M | 1.81% |
81,000
-1,300
| -2% | -$44.5K |
|
|
13
AbbVie
ABBV
$372B
| $2.64M | 1.72% |
46,180
+14,200
| +44% | +$811K |
|
14
Visa
V
$683B
| $2.64M | 1.72% |
34,480
| – | – |
|
15
Ashland
ASH
$2.57B
| $2.49M | 1.62% |
22,655
| – | – |
|
|
16
Novartis
NVS
$245B
| $2.36M | 1.54% |
32,550
+16,300
| +100% | +$1.18M |
|
17
Pfizer
PFE
$141B
| $2.28M | 1.48% |
76,755
+26,427
| +53% | +$783K |
|
18
FedEx
FDX
$54.5B
| $2.22M | 1.45% |
13,660
+2,293
| +20% | +$373K |
|
19
Ecolab
ECL
$78.6B
| $2.16M | 1.41% |
19,395
-25
| -0.1% | -$2.79K |
|
20
American International
AIG
$45.1B
| $2.16M | 1.41% |
40,000
+10,000
| +33% | +$541K |
|
21
Zoetis
ZTS
$69.3B
| $2M | 1.3% |
45,144
| – | – |
|
22
Boeing
BA
$177B
| $1.95M | 1.27% |
15,375
| – | – |
|
23
UnitedHealth
UNH
$281B
| $1.95M | 1.27% |
15,105
| – | – |
|
24
Blackrock
BLK
$175B
| $1.93M | 1.26% |
5,660
| – | – |
|
|
25
Robert Half
RHI
$3.8B
| $1.88M | 1.23% |
+40,400
| New | +$1.88M |
|